Clin 3 (Skin) (15 gm) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Unimarck Pharma (India) Limited. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Nicotinamide, Clindamycin Phosphate. This drug comes in the form of Gel. The general packing available for this medicine consists of 15 gm and is priced at Rs 93 (arround $1.302 US Dollar)
Generic (Salt) Combination :
(Nicotinamide+ Clindamycin Phosphate)
Pharma Company :
Unimarck Pharma (India) Limited
Brand Label :
Clin 3 (Skin) (15 gm)
Preparation Type :
Gel
Single Dose :
15 gm
Composition (Fixed-Dose Combination) :
Nicotinamide-4% w/w Clindamycin Phosphate-1% w/w
Pack Size/Qty/Vol :
15 gm
Price Unit :
Rs 93 INR (arround $1.302 US Dollar)
Price Pack :
Rs 93 INR (arround $1.302 US Dollar)
Drug details for Clin 3 (Skin) (15 gm)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Clin 3 (Skin) (15 gm) are :
Nicotinamide-4% w/w Clindamycin Phosphate-1% w/w
Nicotinamide Indication (Prescribed for or used as):
For more details on Nicotinamide, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Nicotinamide..
Clindamycin Phosphate Indication (Prescribed for or used as):
For more details on Clindamycin Phosphate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clindamycin Phosphate..
Clin 3 (Skin) (15 gm) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 7 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Clin 3 (Skin) (15 gm), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Nicotinamide-4% w/w Clindamycin Phosphate-1% w/w). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.